FibroGen: Q2 Earnings Snapshot
By AP News
Published - Aug 06, 2024, 05:10 PM ET
Last Updated - Aug 06, 2024, 05:11 PM EDT
SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — FibroGen Inc. (FGEN) on Tuesday reported a loss of $15.5 million in its second quarter.
On a per-share basis, the San Francisco-based company said it had a loss of 16 cents.
The biotech drug developer posted revenue of $50.6 million in the period.
_____
